Literature DB >> 95062

Familial exudative vitreo-retinopathy.

J Dudgeon.   

Abstract

Two brothers aged 18 and 14 years showing the features of familial exudative vitreo-retinopathy are described and the treatment of the condition discussed. Two of their cousins aged 9 and 7 1/2 years who showed the presence of congenital retinal folds are also described, and a possible link between the two conditions is postulated. The differential diagnosis is briefly discussed.

Entities:  

Mesh：

Year:  1979        PMID： 95062

Source DB:  PubMed          Journal:  Trans Ophthalmol Soc U K        ISSN： 0078-5334


  7 in total

1.  Reduced bone mineral density and hyaloid vasculature remnants in a consanguineous recessive FEVR family with a mutation in LRP5.

Authors:  L M Downey; H M Bottomley; E Sheridan; M Ahmed; D F Gilmour; C F Inglehearn; A Reddy; A Agrawal; J Bradbury; C Toomes
Journal:  Br J Ophthalmol       Date:  2006-09       Impact factor: 4.638

2.  Electrophysiological findings in familial exudative vitreoretinopathy.

Authors:  H Ohkubo; T Tanino
Journal:  Doc Ophthalmol       Date:  1987-04       Impact factor: 2.379

3.  Dominant exudative vitreoretinopathy and other vascular developmental disorders of the peripheral retina.

Authors:  C E van Nouhuys
Journal:  Doc Ophthalmol       Date:  1982-09-23       Impact factor: 2.379

4.  Familial exudative vitreoretinopathy.

Authors:  W E Benson
Journal:  Trans Am Ophthalmol Soc       Date:  1995

5.  Congenital retinal fold as a sign of dominant exudative vitreoretinopathy.

Authors:  C E van Nouhuys
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1981

6.  X linked exudative vitreoretinopathy: clinical features and genetic linkage analysis.

Authors:  P Fullwood; J Jones; S Bundey; J Dudgeon; A R Fielder; M W Kilpatrick
Journal:  Br J Ophthalmol       Date:  1993-03       Impact factor: 4.638

7.  Analysis of Predisposing Clinical Features for Worsening Traction After Treatment of Familial Exudative Vitreoretinopathy in Children.

Authors:  G Baker Hubbard; Alexa L Li
Journal:  Am J Ophthalmol       Date:  2020-07-21       Impact factor: 5.258
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.